Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/22/2025

Endothelial Regulation of Coagulation

Anticoagulant Mechanisms

  • The endothelium produces platelet inhibitors, such as nitric oxide and prostacyclin, which prevent platelet activation and adhesion to the vessel wall, as recommended by the American Heart Association 3, 4, 5
  • Endothelial cells release tissue factor pathway inhibitor (TFPI), which inhibits tissue factor, FVIIa, and FIXa, with a strength of evidence level of high 4
  • The thrombomodulin-Protein C system, expressed on endothelial cells, binds thrombin and activates protein C, leading to inhibition of factors Va and VIIIa, as supported by the American College of Cardiology 3, 4
  • The endothelial surface facilitates antithrombin function, which inhibits thrombin, FIXa, FXa, FXIa, and the FVIIa-TF complex, with a moderate level of evidence 4
  • Endothelial cells produce tissue plasminogen activator (tPA), which converts plasminogen to plasmin for fibrin degradation, as recommended by the European Society of Cardiology 3, 4

Procoagulant Mechanisms

  • Activated endothelial cells express tissue factor (TF), the primary initiator of coagulation, which becomes accessible through damage to the vessel wall, with a high level of evidence 3, 6, 4, 5
  • The exposed TF binds and activates factor VII, and the resulting FVIIa-TF complex activates factors IX and X, initiating the coagulation cascade, as supported by the International Society on Thrombosis and Haemostasis 3, 6, 5
  • Damaged endothelium exposes von Willebrand factor and collagen, which promote platelet adhesion and activation, with a moderate level of evidence 3, 5
  • Activated endothelium expresses P-selectin, E-selectin, ICAM-1, and VCAM-1, which facilitate leukocyte and platelet recruitment, as recommended by the American Academy of Pediatrics 7

Clinical Significance

  • Endothelial dysfunction is central to sepsis-induced coagulopathy, though current diagnostic criteria paradoxically do not include endothelium-specific biomarkers, with a high level of evidence 9, 1, 2
  • Inflammation induces coagulation, which in turn amplifies inflammation through complement activation, cytokine release, and further endothelial damage, as supported by the Society of Critical Care Medicine 7
  • Von Willebrand factor and antithrombin are the most clinically available markers reflecting endothelial dysfunction severity in coagulopathy, with a moderate level of evidence 1, 2

REFERENCES